BENGALURU: Australian shares ended lower on Friday, as the country joined a host of others in restricting the use of AstraZeneca's COVID-19 vaccine and began overhauling its inoculation plans, though the index still delivered its best week in nine.
The S&P/ASX 200 index settled 0.1% lower at 6,995.2 points at close of trade, applying brakes on its longest winning run since early December.
Australia on Thursday made a policy shift to recommend the use of Pfizer's COVID-19 vaccine for people over 50 amid concerns about links to risks of blood clots with AstraZeneca's shot.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
